Cifoban Fresenius Medical Care Australia Pty Ltd
Product name
Cifoban
Accepted date
Jan-2024
Active ingredients
sodium citrate dihydrate
Proposed indication
Cifoban is used for regional citrate anticoagulation (RCA) in continuous venovenous haemodialysis (CVVHD), continuous venovenous haemodiafiltration (CVVHDF), sustained low efficiency (daily) dialysis (SLEDD) and therapeutic plasma exchange (TPE) via membrane plasma separation.
Application type
A (new medicine)
Publication date
Jan-2024